analysis of most common endogenous steroids in plasma721937/... · 2014. 6. 5. · 1.2.2 analytical...
TRANSCRIPT
Master thesis 45 hp
March 2014
Analysis of most common endogenous steroids in
plasma
Wenjun Zhao
Degree project in analytical chemistry, Master of Science (2 years)
Supervisor: Dr. Kumari Ubhayasekera
Analytical Chemistry, Department of Chemistry BMC and Science for Life Laboratory (SciLife),
Uppsala University
Box 599, 75124 Uppsala, Sweden.
ISRN UU MASTERUTB-EX--(M2014: ) Examiner: Christer Elvingson
1
Contents Abstract ......................................................................................................................................................... 3
List of Abbreviations .................................................................................................................................... 4
1. Introduction ............................................................................................................................................... 6
1.1 Endogenous steroid hormones and their metabolites .......................................................................... 8
1.2 Analytical methodology ...................................................................................................................... 9
1.2.1 Sample preparation ...................................................................................................................... 9
1.2.2 Analytical techniques for steroid analysis .................................................................................. 10
1.3 Scope of this study ............................................................................................................................ 13
2. Materials and methods ............................................................................................................................ 14
2.1 Chemicals and reagents ..................................................................................................................... 14
2.2 Standard solutions ............................................................................................................................. 14
2.3 Optimization of sample preparation .................................................................................................. 15
2.4 TLC analysis ..................................................................................................................................... 16
2.5 Sample- free plasma preparation ....................................................................................................... 16
2.5.1 Using ISOLUTE SI 6 ml SPE column ....................................................................................... 16
2.5.2 Using charcoal method............................................................................................................... 16
2.6 Steroids extraction using ISOLUTE SLE + 96-well plates .............................................................. 17
2.7 Method validation ............................................................................................................................. 17
2.8 Instrumentation ................................................................................................................................. 18
3. Results and discussion ............................................................................................................................ 19
3.1 Identification of each steroid............................................................................................................. 20
3.2 Optimized derivatization conditions ................................................................................................. 27
3.3 Retention times and specificity ......................................................................................................... 31
3.4 Steroid-free experiments ................................................................................................................... 32
3.5 Method validation ............................................................................................................................. 33
3.5.1 Calibration curve for each steroid .............................................................................................. 33
3.5.2 Limit of detection (LOD), limit of quantification (LOQ) and precision. ................................... 35
3.5.3 Normal sample analysis ............................................................................................................. 36
3.5.4 Recovery test .............................................................................................................................. 36
4. Conclusion .............................................................................................................................................. 38
5. Future work ............................................................................................................................................. 38
2
6. Acknowledgments ................................................................................................................................... 39
7. Popular scientific summary ..................................................................................................................... 40
8. References ............................................................................................................................................... 42
3
Abstract
Steroid hormones are biologically active low molecular weight lipid compounds which are synthesized
from cholesterol. These steroids are important in controlling human body functions and regulating the
nervous and immune systems. Therefore, a sensitive, stable and rapid method for the analysis and
quantification of steroids in the human plasma is necessary in pharmacokinetic studies. This work is
establishing a novel GC-MS method for the simultaneous determination of as many as 9 analytes covering
3 classes of endogenous steroids.
The methoxylation and silylation conditions for steroids were optimized in this work. The linearity of the
GC-MS method was evaluated at the steroids concentration range of 2 – 50 µg/ml. Correlation coefficient
(R2) of cholesterol and estradiol ≥ 0.99; both dehydroepiandrosterone and cortisone’s parameters ≥ 0.93.
The recoveries for all the steroids determined at low, medium and high concentration levels varied from
52.70 – 162.78 %. The concentration of cholesterol in normal plasma is 34.82 ± 1.35µg/ml.
Keywords
Steroids, methoxylation, silylation, GC-MS, quantification, human plasma
4
List of Abbreviations
AS Androsterone
BSA N,O-Bis(trimethylsilyl)acetamide
BSTFA N,O-Bis(trimethylsilyl)trifluoroacetamide
BSTFA+TMCS N,O-Bis(trimethylsilyl)trifluoroacetamide and trimethylchlorosilane
C2Cl3F3 1,2,2-trichloro-1,2,2-trifluoroethane
CAN Concentration of the analyte
CIS Concentration of the internal standard
CHOL Cholesterol
DHEA Dehydroepiandrosterone
DTE Dithioerythritol
E Cortisone
E1 Estrone
E2 Estradiol
E3 Estriol
ECN Etiocholanolone
EI Electron impact
GC Gas chromatography
GC–MS/MS Gas chromatography mass spectrometry
HDL High-density lipoprotein
HFBA Heptafluorobutyric Acid
HPLC High performance liquid chromatography
IS Internal standard
LC–MS/MS Liquid chromatography tandem mass spectrometry
LOD Limit of detection
LOQ Limit of quantification
MS Mass spectrometry
MSTFA N-Methyl-N-(trimethylsilyl)trifluoroacetamide
m/z Mass-to-charge ratio
Rt Retention time
SD Standard deviation
S/N Signal-to-noise ratio
5
SIM Selected ion monitoring
SPE Solid-phase extraction
T Testosterone
TBDMCI tert-Butyldimethylsilylchlorosilane
TEA Triethylaluminium
TMIS Trimethyliodosilane
TMS Trimethylsilyl
TMSI N-trimethylsilylimidazole
TMCS Trimethylchlorosilane
6
1. Introduction
Steroid hormones are biologically active low molecular lipid compounds which are synthesized from
cholesterol (figure 1.1). All the steroid hormones have a tetracyclic base structure which consists of four
fused rings: three cyclohexane rings and one cyclopentane [1]; the chemical structure and IUPAC names of
the steroids of interest are listed in table 1.1.
These steroids are important in controlling human body functions and regulating the nervous and immune
systems [2, 3]. In recent years, steroids have became useful biomarkers for the diagnosis of several
pathological conditions [4]. Therefore it is important to improve and continue developing new analysis
methods. The most important requirements for the techniques of steroid measurement are reliability,
specificity and sensitivity. The tandem mass spectrometry (MS/MS) technique can satisfy these
requirements, hence mass spectrometry (MS) coupled with gas chromatography (GC) or high performance
liquid chromatography (HPLC) is commonly used in steroid hormone detection during modern times [34].
Figure 1.1: Biosynthesis of steroid hormones in the cholesterol pathway
(http://en.wikipedia.org/wiki/File:Steroidogenesis.svg)
7
Table 1.1. List of the names, abbreviations and chemical structures of the investigated steroids.
IUPAC Common name Abbreviation Chemical structure
(3β)-Cholest-5-en-3-ol Cholesterol CHOL
3-Hydroxyestra-1,3,5(10)-trien-
17-one
Estrone E1
(17β)-Estra-1,3,5(10)-triene-
3,17-diol
Estradiol E2
(16α,17β)-Estra-1,3,5(10)-
triene-3,16,17-triol
Estriol E3
(3β)-3-Hydroxyandrost-5-en-
17-one
Dehydroepiandroster
one
DHEA
(3α,5α)-3-Hydroxyandrostan-
17-one
Androsterone AS
(3α,5β)-3-Hydroxyandrostan-
17-one
Etiocholanolone ECN
(17β)-17-Hydroxyandrost-4-en-
3-one
Testosterone T
11,17,21-Trihydroxypregn-4-
ene-3,20-dione
Cortisone E
The aim of this work is to develop and optimize a GC–MS/MS analytical method to serve as a diagnostic
test for steroids/biomarkers of endocrine and metabolic diseases.
8
1.1 Endogenous steroid hormones and their metabolites
The steroids that will be measured in this study are divided into the following catogories: estrogen; androgen;
and glucocorticoid, with their respective metabolites. Steroid hormones are synthesized from cholesterol
(CHOL) which can be transformed into other steroids (figure1.1).
Steroids with their metabolites show great clinical effectiveness as biomarkers for disease detection. Fouad
(et al) found that the concentration levels of steroids could indicate some disorders such as defective
steroidogenesis and other related clinical diseases [5];
Other impacts of steroids on the human body are list in table 1.2.
Table 1.2. List of the steroids and their metabolites and some effects in the human body.
Steroid and Metabolite Impact
Cholesterol It can control membrane fluidity over the range of physiological
temperatures and functions in intracellular transport, cell signaling
and nerve conduction [6].
Estrone It is a known carcinogen for human females [7].
Estradiol It could protect women from heart disease by raising the level of
HDL and protect bone density in both men and women [8].
Estriol In pregnant women with multiple sclerosis, it reduces the disease's
symptoms [9].
Dehydroepiandrosterone It works as a metabolic intermediate in the biosynthesis of the
androgen and estrogen sex steroids [10].
Androsterone It would influence human behavior and low levels could be the major
correlate of decreased sexual desire [11].
Etiocholanolone It would cause fever, immune stimulation and leukocytosis [12].
Testosterone Development of male reproductive tissues such as the testis and
prostate as well as promoting secondary sexual characteristics [13].
Cortisone It can elevate blood pressure and prepare the body for a fight or flight
response [14].
Synthesis of steroids occurs in the mitochondria and the smooth endoplasmic reticulum of cells in the
adrenal cortex, the gonads and the placenta [15]. The adrenal cortex is mainly responsible for the production
of corticosteroid and androgen hormones which has three zones. Aldosterone and mineralocorticoids are
mainly produced in the outmost zone and zona glomerulosa [16]. The middle zone, zona fasciculate, releases
glucocorticoids such as cortisol and cortisone into the body. Zona reticularis and the innermost zone is
responsible for producing androgens like dehydroepiandrosterone (DHEA) and androstenedione (the
precursor to testosterone (T)) [16]. Estrogens (E1, E2 and E3) are produced mainly by the ovaries and
placenta with small amounts being produced by the adrenal glands.
9
1.2 Analytical methodology
1.2.1 Sample preparation
Extraction/Purification
Common biological samples used for analysis of steroids includes serum, plasma, urine and saliva. Sample
sizes typically ranges from a few microliters to 1mL. Sample preparation for steroid analysis generally
involves extraction and enrichment. Extraction techniques are usually compound specific and depend on
the sample type, requiring sensitivity and high throughput. Routine sample preparation usually consist of
liquid-liquid extraction (LLE), protein precipitation and solid phase extraction (SPE) [17].
Derivatization
i. Silylation
Most steroids are required to be derivatized before injection into GC-MS. Silylation is one of the most
common techniques employed in steroid derivatization. The reaction occurs by substituting the proton in
hydroxyl (-OH), amino (-NH2) and sulfide (-SH) groups with a silyl group (R3Si) [18].
Some of the most common reagents used for derivatization, include MSTFA[19-26], TMIS[23,24], DTE[24,27],
BSTFA[24], trimethylsilylimidazole(TMSI)[24,27-29], trimethylchlorosilane (TMCS)[24] , HFBA[25,30] and
TEA[25]. To enhance the derivatization efficiency, these reagents are sometimes mixed in different ratios.
For example, Cangialosia et al. [21], mixed MSTFA and TMIS in a ratio of 1000 to 2 (v/v) for derivatization
at 60°C for 15 min, and shown a good sensitivity. Other derivatization mixtures have also been used, namely
MSTFA, TMIS and DTE (1000:2:5, v/v/w); BSTFA and 1% TMCS; MSTFA and 1% TMCS; BSTFA and
1% TMSI; MSTFA and 1% TMSI; a good linearity of response with a coefficient R2 > 0.994 was obtained;
Limits of detection (LODs) ranging from 0.01 to 1.0 ng/mL for all steroid hormones were also obtained;
All the derivatives were stable for quite some time (24-48 hours) [24]. The conditions for derivatization were
as follows: MSTFA with 2.0% NH4I and 1.5% dithioerythritol (v/w/w) was heated for 10 min at 90°C and
the lowest quantification limits were reported to be from 0.002 to 0.6 μg/L for 1.0 mL of saliva [26].
From the discussion above, it is clear that the optimization of derivatization conditions still remains a big
challenge in the determination of steroids.
10
ii. Methoxylation
Steroids containing ketone groups such as cortisone or cortisol sometimes cannot be detected by GC–MS
after silylation. Normally, the ketone group of these compounds should be derivatized by methoxylamine
or ethoxylamine to form a stable oxime. The methoxylation reagent can be used separately or coupled with
a silylation step [31].
1.2.2 Analytical techniques for steroid analysis
Currently, the main techniques employed for the analysis of steroids are immunoassays [32, 33], LC–MS [34,
35-37] and GC–MS/MS [30, 34, 38-44]. However, immunoassays are mainly applied in the analysis of clinical
disorders influenced by cross-reactions, thus negatively affecting the results. The latest techniques are
mainly GC–MS and LC–MS based. Both of these techniques are superior to immunoassays in terms of
increased specificity, quantification and linearity.
GC–MS/MS method
The principle of GC–MS is that gas-phase ions are separated according to mass-to-charge (m/z) ratio and
then sequentially detected in single and multiple modes. A GC–MS instrument is divided into four major
parts, i.e. sample introduction, ion source, mass analyzer and detector. A typical schematic diagram of a
GC–MS/MS system is shown in figure 1.2.
11
Figure 1.2: Schematic diagram of Scion GC-MS/MS and q0 is ion guide of this instrument
GC–MS is normally used as the predominant method in the determination of steroids in human plasma,
because it ensures high specificity and sensitivity as well as a low limit of detection (LOD) [45]. According
to Thenot and Horning all possible steroids with their metabolites can be detected by GC–MS [46]. In 1960,
the analysis of steroids by GC was described for the first time by Van den Heuvel [19] who used cholestane
as internal standard (IS), and reported that the compounds with a hydroxyl group eluted before the
compounds with a ketone group. Four years later, in 1964, Ryhage reported on coupling GC with MS for
the first time [47]. This invention paved the way for the determination of the structures of known and
12
unknown steroids [47]. The mass analyzer of most GC–MS systems can be operated in full scan mode and/or
selected ion monitoring mode. This provides the operator with the opportunity to detect most of the
compounds present in a sample or to detect only a selected few. A review of the literature on steroid analysis
revealed reports on the simultaneous determination of some of the steroids of interest as well as methods
for individual detection [27, 30].
It has been reported by Jun Chen, et al (2009) that DHEA, cortisol (E), estrone (E1), 17β-estradiol (E2), T
and androsterone (AS) were analyzed simultaneously and the resulting detection limit (LOD) and limit of
quantification (LOQ) range show that the sensitivity is quite good and stable[30]. Martin et al.[27] also found
the concentration levels of estrogen and androgen groups in the plasma and serum, down to 0.08–0.16
ng/mL and 0.20 – 0.36 ng/mL, respectively; the accuracy of this method was 50–112% in the range 0.10 to
2.00 ng/mL.
LC–MS/MS method
GC–MS methods are well suited for the analysis of almost all steroids and their metabolites, however, some
steroids and their metabolites are preferably analyzed using LC–MS/MS methods; e.g. corticosterone[48],
tetrahydrocortisol[49,50], and tetrahydrocorticosterone[51], to name a few. All the results show good sensitivity
and reproducibility.
Comparison of GC–MS and LC–MS/MS techniques for steroid analysis
GC–MS offers higher resolution than LC–MS/MS due to the longer analysis running time. For some
diastereomeric compounds, GC–MS has better separation than LC–MS/MS, which renders it more useful
in the diagnosis of some metabolic disorders like apparent cortisone reductase deficiency (ACRD) [54]. GC–
MS is also a good tool for analyzing non-target steroids, especially when used in full scan mode which
enables storage of the fragmentation information for evaluation at a later stage. This is very useful in, for
example, the field of sports for the randomized anti-doping analysis of athletes’ body fluid samples which
can be re-checked for previously unidentified drugs [34]. GC-MS needs less sample volume than LC-MS
however GC-MS is more sensitive than LC-MS.
13
Table 1.3: Advantages and disadvantages of the current methods for analysis of steroids
Method Advantage(s) Disadvantage(s)
GC–MS Good resolution and can be used for
volatile compounds
High sensitivity/ throughput
Small sample volume
High cost and time consuming sample
preparation procedures
Cannot be used for non-volatile and
thermal unstable molecules
LC–MS/MS Shorter analysis time and can be used for
non-volatile and high molecular weight
compounds
Not good for volatile compounds
Immunoassay Simple, rapid, inexpensive Overestimate steroid concentrations
One of the biggest drawbacks of GC–MS is that it is marked by a time consuming sample preparation step
which is often less prominent in LC–MS/MS. In many cases, derivatization of steroids are needed, which
usually include methoxylation of ketone groups and silylation of hydroxyl groups, to improve their
volatility when using GC–MS. After derivatization, compounds can give a mass fragmentation of the
molecular ion, so it is easier for determination the functional groups on the steroid [18].
After a comparison of these two techniques, it is evident that GC–MS is a powerful tool that can be
employed for the analysis of steroids, especially unknown steroids, despite being prone to time-consuming
sample preparation steps and longer analysis times [54, 55]. The advantages and disadvantages of these
methods for the analysis of steroids are summarized in Table 1.3.
1.3 Scope of this study
The main objective of this study was to develop a GC–MS method for the complete separation and
quantification of several steroids to use as a diagnostic test for steroid/biomarkers of endocrine and
metabolic disease. Optimizations of sample preparation and clean-up steps as well as derivatization
conditions are needed. After method development and optimization, the method should be evaluated and
applied in analyzing biological tissues and fluids.
14
2. Materials and methods
2.1 Chemicals and reagents
Cholesterol (CHOL), estrone (E1), estradiol (E2), estriol (E3), dehydroepiandrosterone (DHEA),
androsterone (AS), etiocholanolone (ECN), testosterone (T) and cortisone (E) were purchased from
Steraloids (Newport, RI, USA). 5α-Cholestane(C27H48) was used as internal standard (IS); N,O-
bis(trimethylsilyl)acetamide (BSA); N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA), BSTFA with 1%
trimethylchlorosilane (BSTFA+TMCS), tert-butyldimethylsilylchloride (TBDMCL); 1,1,1,3,3,3-
hexamethyldisilane + trimethylchlorosilane + pyridine (HMDS+TMCS+Pyridine (3:1:9)); methoxyamine
hydrochloride and anhydrous pyridine (99.8%) were obtained from Sigma-Aldrich (Stockholm, Sweden).
All chemicals and chromatographic reagents used were of analytical grade. All other chemicals and reagents
were purchased from Merck, Eurolab (Stockholm, Sweden), unless otherwise stated. Ultrapure water was
deionized and osmosed with a MilliQ purification system (Millipore, Bedford, MA, USA) was used.
2.2 Standard solutions
Stock solutions (1 mg/mL) of all steroids were prepared by weighing off, with analytical precision, each
steroid and dissolving it in ethanol. A stock solution of 100 ng/µL in ethanol was prepared for the internal
standard. The stock solutions were kept in a freezer at -20 °C within tightly capped glass tubes. In order to
obtain the working solutions and calibration standards at different concentrations, the stock solutions were
diluted with methanol (MeOH). The concentration of methoxyamine hydrochloride was 20 mg/mL in
anhydrous pyridine.
Working solutions and calibration standards were prepared by a general protocol. After pipetting 20 µL
from stock solution (1mg/mL) and 100µl from internal standard solution (100ng/µL) into a glass tube, the
solvent was evaporated by a gentle flow of nitrogen gas. The methoxylation reagent (30 µL) was added.
The glass tube was kept in an oven at 60°C for 45min. After incubation, the solvent was evaporated and
100 µL of silylation reagent was added to the sample. The samples were incubated again at 120°C for 30
min. Then the solution was cooled to the room temperature and the solvent was evaporated under nitrogen
gas. Finally 100 µL of C2Cl3F3 was added. The solution was centrifuged at room temperature at 3,000 × g
for 5 min. The solution was transferred to a small GC vial and injected into the GC–MS instrument for
analysis.
15
2.3 Optimization of sample preparation
Methoxylation
Different methoxylation conditions were investigated. Therefore, one sample from each set was paired and
subjected to the same set of incubation conditions for methoxylation as shown in Table 2.1. Methoxyamine
hydrochloride in pyridine was used as methoxylation reagent. After methoxylation of the compounds, the
silylation reagent was added to each set and incubated.
Table 2.1: Different incubation conditions for methoxylation of standards.
Set Name of silylation reagent
(100µL)
Incubation conditions
for methoxylation (30µL)
Incubation conditions
for silylation (100µL)
A
BSA
60°C for 30 min
120°C for 30min 60°C for 45min
70°C for 30min
B
BSTFA
60°C for 30 min
120°C for 30min 60°C for 45min
70°C for 30min
Silylation
Different silylation conditions were investigated. Five different silylation reagents or mixtures, namely
BSA, BSTFA, HMDS+TMSC, TBDMCI and BSTFA+TMCS, were investigated by incubating at different
temperatures and inclubation times and the conditions are shown in Table 2.2.
Table 2.1: Different incubation conditions for silylation of standards.
Set Name of silylation
reagent (100µL)
Incubate condition for the
methoxylated derivatization(30µL)
Incubate condition
for the silylation
A BSA 60°C for 45min 70°C for 1 hour
120°C for 30 min
B BSTFA 60°C for 45min 70°C for 1 hour
120°C for 30 min
C HMDS+TMCS 60°C for 45min 70°C for 1 hour
120°C for 30 min
D TBDMCL 60°C for 45min 70°C for 1 hour
120°C for 30 min
16
E BSTFA+TMCS 60°C for 45min 70°C for 1 hour
120°C for 30 min
The working flow diagram of experiment with standards
Pipette 20µl from each steroid stock solution and 100µl from internal standard solution evaporate
solvent add 30µl methoxylation reagent keep the tube in the oven at different programs
evaporate solvent add silylation reagent 100 µl into the mixture solution under the N2 gas flow
keep in the oven at different programs evaporate solvent the derivatized standards re-dissolved
in 100µl C2Cl3F3 centrifuge for 5min GC-MS/MS analysis
2.4 TLC analysis
To check the completion of derivatization, underivatized and derivatized steroids were analyzed by
analytical pre-modified silica with aliphatic hydrocarbons. The TLC plates silica gel 60, 20 × 20 cm, 0.25
mm thickness were used (Merck, Eurolab AB, Stockholm, Sweden) to check visually the completeness of
derivatization. The derivatized samples along with the standard steroids (underivatized) as TLC-references
(Steraloids, Newport, RI, USA), were spotted onto a TLC plate and developed in the solvent system diethyl
ether: cyclohexane (90:10, v/v). The TLC plate was dried briefly in air and then sprayed with 10 %
phosphomolybdic acid in diethyl ether: ethanol (50:50, v/v). The plate was placed in an oven at 120 ºC for
15 min for color development.
2.5 Sample- free plasma preparation 2.5.1 Using ISOLUTE SI 6 ml SPE column
Normal plasma (1mL) was diluted with 1mL hexane: diethyl ether (9:1 v/v) and vortexed at room
temperature. The diluted sample was loaded onto an ISOLUTE SI 6 ml SPE cartridge (pre-conditioned with
5ml hexane). After distribution of the aqueous phase in the column, the steroids of interest were eluted with
15ml hexane: diethyl ether (9:1 v/v). After that process, washing with 10ml hexane: diethyl ether (1:1 v/v)
again. Finally, elution of pure steroid free plasma with 10ml acetone into silanized glass tubes. The collected
elution was dried under the N2 gas after the methoxylation and silylation process. The sample solution was
compared with the standard cholesterol solution using a TLC plate to check if the steroids were removed.
2.5.2 Using charcoal method
The steroid-free plasma was prepared by activated charcoal as described by Aburuz et al [56]. Two sets of
normal plasma (200µl) were prepared, one set without charcoal and one set with 8mg charcoal then vortexed
17
and centrifuged. After the filtering, Methanol: CHCl3 (2:1, v/v) was added twice into these two sets of
plasma samples. The sample solution dried under the N2 gas after the methoxylation and silylation process.
It was then compared with the standard cholesterol solution using a TLC plate to check if the steroids were
removed.
2.6 Steroids extraction using ISOLUTE SLE + 96-well plates
Normal plasma (100µl) with 2µg internal standard was diluted with MQ water (100µl). The pre-treated
sample (200µl) was loaded into a plate followed by a pulse of vacuum to initiate flow and left for 5 minutes.
Then eluted with dichloromethane (1ml) dropped directly into a deep well collection plate which was left
for 5 minutes. Then a short pulse of vacuum was applied. The eluent was collected followed by
methoxylation and derivatization and finally injected into GC-MS.
2.7 Method validation
The proposed method was validated using spiked plasma samples as described in the guidelines by the FDA
(http:\\www.fda.gov\cder\guidance\4252fnl.pdf.2001). The method was validated using four different
steroids (CHOL, E2, DHEA and E). Stock solution of steroids and IS (Cholestane) were prepared
independently at 1mg/mL in ethanol and stored at -20˚C. Prior to the measurements, these solutions were
serially diluted with the same solvent and further used for the calibration and quality control (QC).
Linearity
In order to accurately quantify the targeted steroids, the measured response must be correlated with the
concentration of the steroid hormones. Therefore, calibration curves need to be constructed. Calibration
standards of CHOL, E2, DHEA and E were prepared from 1 mg/mL stock solutions according to the general
protocol described in section 2.2. The standards for CHOL, E2 and DHEA were prepared to a final
concentration of 2, 4, 10, 15, 25 and 50 µg/mL and E was 50, 75, 100, 150 and 200 µg/mL in triplicate,
respectively. Each sample contained 15 µg/mL of the internal standard. The calibration range reflected the
steroid concentration levels in the human body and the number of replicates was sufficient to determine
certain parameters and perform various statistical analyses (linearity, precision, accuracy, sensitivity,
stability, limit of detection, etc.). Samples were run in triplicates. Calibration curves were separately
prepared by plotting the peak area ratio of each steroid area of IS against the concentration of each
compound. The linearity was determined by linear regression analysis.
18
The ratio of the integrated peak areas (AAN)/(AIS) and the concentration ratio (CAN/CIS) of the analyte (AN)
and internal standard (IS) were calculated. Calibration curves of (AAN)/(AIS) versus (CAN/CIS) were
constructed for each compound. A linear relationship over the analyte concentration range was displayed
by all four calibration curves.
Precision and accuracy
Quality control samples were used for precision and accuracy determination on intra-day and inter-day
basis. The intra-day (n=3) and inter-day precisions (n=6) were determined for the spiked samples.
Limit of detection and quantification
The detection limit (LOD) and the quantification limit (LOQ) were calculated using calibration curves for
samples spiked with steroids. LOD was calculated using the formula 3.3 δ/S and LOQ was obtained by the
formula 10 δ/S, here δ is the residual standard deviation of the regression line and S is the slope of the
regression line.
Recovery
Samples were spiked in triplicates with known amounts of four different steroids at five different
concentration levels (CHOL, E2, and DHEA was 500ng, 1000ng, 2000ng, 3000ng and 5000ng; E was
5000ng, 7500ng, 10000ng, 12500ng and 15000ng respectively) and analyzed to determine the recovery of
each steroid.
2.8 Instrumentation
Analysis of steroids was performed using a triple quad mass spectrometer coupled to the gas chromatograph
(SCION TQTM GC-MS/MS System, Billerica, MA, USA). Separation of steroids was performed on a non-
polar capillary column (DB-5MS, J&W Scientific, Folsom, CA, USA), 30 m 0.18 mm 0.18 m film
thickness. Helium was the carrier gas at a linear velocity (1 mL/min). The injector temperature was 250°C
and the samples were injected using the split injection mode (20:1). The oven temperature was 120°C
followed by an increase of 50°C /min to 240°C and an isothermal hold of 1 min, then ramping at 1.5°C
/min to 250 °C, after that increasing of 10°C /min to 260°C, finally by an increase of 50°C /min to 320°C
with a hold of 5 min, total running time was 17.27 min. The ionization mode was electron impact (EI). The
mass spectra were recorded at an electron energy of 70 eV and the ion source temperature was 260°C. The
transfer line temperature was 300°C. The spectra were scanned in the range of 50-600 m/z. Identification
19
of the steroids was done by comparing the mass spectra of standard samples of the steroids and their
retention times. Chromatograms were collected in full scan mode (TIC). Quantification of the steroids was
accomplished using cholestane as an internal standard due to its physical and chemical behavior similar to
that of target analyte as well as its absence in biological samples. Quantification of steroids (area response)
was accomplished with the help of the internal standard.
3. Results and discussion
A simple analytical procedure for the simultaneous determination of 9 steroids by a GC-MS/MS method
has been developed. Many target analytes are not intrinsically volatile and will decompose during the
transition between the liquid and gas phase inside the injection port or during elution from the
column at high temperatures. Consequently, several steps, including pre-analytical derivatization, are
required for steroid analysis by GC/MS. The derivatization is one of the main steps in the sample
preparation. This step is required to improve the volatility and thermal stability of steroids. Derivatization
of steroids is generally required before analyzing by GC-MS/MS. This process often time consuming.
In the present study, several strategies have been employed to enhance this process, like incubation
temperature, time of incubation and different silylating reagents.
Mass spectrometry is the most recent method that has wide acceptance in the steroid field. GC for
separation prior to MS (GC/MS) is used, due to the relative ease of coupling these orthogonal
techniques with respect to the vacuum considerations. Given the high resolving capability of a GC
equipped with a modern capillary column and the superb precision of MS, GC/MS systems have been
a mainstay of analytical chemistry. To facilitate the interpretation and discussion of the results, mass
spectrometry identification of steroids is briefly discussed below (Figure 3.1).
20
c
Figure 3.1: a Schematic diagram of a simple mass spectrometer with source, quadrupole, and
detector, sorting ions by m/z. b Generation of a mass spectrum for a pure compound. The
molecular ions fragment, and the charged fragments are separated by the quadrupole and
quantitated by the detector, yielding a standard mass spectrum. c Mass spectrum of
testosterone.
During the methoxylation reaction a methyl group (–CH3) from the methoxylation reagent, with a
molecular mass of 15 Da, binds to the oxygen of a ketone group of the steroid. A trimethylsilyl
group (–Si(CH3)3) from the silylation reagent, with a molecular mass of 73 Da, will attach to the
oxygen of a hydroxyl group of the steroid.
3.1 Identification of each steroid
The MS detection of every steroid showed abundant molecular ions [(M-n×H) +n×73+m×15]+, or [(M-
n×H) +n×73]+ (M represents the molecular weight of each steroid, n represents the number of hydroxyl
groups and m represents the number of ketone groups) providing evidence of the steroid's molecular weight
(Table 1.1).
21
Figures 3.2-3.12 illustrate the chromatogram and mass spectrum using full scan mode for each steroid.
1) The molecular mass of cholesterol is 386.65 Da (Table 1.1) and the structure has one hydroxyl
group. The MS detection of cholesterol showed an abundance singly charged molecular ions [(M-
H) +73]+ at m/z of 458 providing evidence of cholesterol. Also fragments of m/z 129, 329 and 368
could be detected. The mass to charge ratio m/z of 129 is a basic fragment formation for identifying
steroids; also [M-H2O] gave the formation of m/z at 368. As we can see from the figure, the intensity
of the molecular ion with m/z of 458 was relatively low comparing with the other fragments due to
that the EI source is a hard ionization technique with high voltage so that most of analyte would be
fragmented and leaving a weak molecular ion peak.
Figure 3.2: Representative cholesterol chromatograms and mass spectrum; cholestane was the internal
standard. The molecular ion m/z is 458.
2) The molecular mass of androsterone is 290.44 Da (table 1.1); the structure has one ketone group
and one hydroxyl group, respectively. During the methoxylation process, the ketone group cannot
be completely converted to a methoxy group, so androsterone would show two peaks after GC
separation. The MS detection of androsterone showed one charged molecular ions [(M-H)+73]+ at
m/z of 362.3 and another was [(M-H) +73+15]+ at 377.3 providing evidence of androsterone. Figure
3.2 shows androsterone with one TMS group (m/z 362.3) and figure 3.3 shows androsterone with
one TMS group and one methoxy group (m/z 377.3).
22
Figure 3.3: Representative Androsterone-TMS chromatograms and mass spectrum; cholestane was the
internal standard. The molecular ion m/z is 362.3.
Figure 3.4: Representative Androsterone-TMS-CH3 chromatograms and mass spectrum; cholestane was
the internal standard. The molecular ion m/z is 377.3.
3) The molecular mass of etiocholanolone is 290.44 Da (table 1.1), the structure of etiocholanolone
has one ketone group and one hydroxyl group, respectively. The ketone group can be completely
converted to a methoxy group. The MS detection of etiocholanolone showed an abundance singly
charged molecular ions [(M-H) +73+15]+ at m/z of 377.4 providing evidence of etiocholanolone.
23
Figure 3.5: Representative etiocholanolone chromatograms and mass spectrum; cholestane was the
internal standard. The molecular ion m/z is 377.4.
4) The molecular mass of DHEA is 288.42 Da (table 1.1). The structure of DHEA has one ketone
group and one hydroxyl group, respectively. The ketone group can be converted to methoxy group
completely. The MS detection of DHEA showed an abundance singly charged molecular ions [(M-
H) +73+15]+ at m/z of 375.4 providing evidence of DHEA.
Figure 3.6: Representative DHEA chromatograms and mass spectrum; cholestane was the internal
standard. The molecular ion m/z is 375.4.
5) The molecular mass of estrone is 270.37 Da (table 1.1). The structure of estrone has one ketone
group and one hydroxyl group, respectively. During the methoxylation process, the ketone group
cannot be completely converted to a methoxy group, so the estrone still show two peaks in the
chromatogram. The MS detection of estrone showed one charged molecular ion [(M-H) +73]+ at
24
m/z of 342.3 and another was [(M-H) +73+15]+ at 357.4 providing evidence of estrone. Figure 3.7
shows estrone with one TMS group (m/z 342.3) and figure 3.8 shows estrone with one TMS group
and one methoxy group (m/z 357.4).
Figure 3.7: Representative estrone-TMS chromatograms and mass spectrum; cholestane was the internal
standard. The molecular ion m/z is 342.3.
Figure 3.8: Representative estrone-TMS-CH3 chromatograms and mass spectrum; cholestane was the
internal standard. The molecular ion m/z is 357.4.
6) The molecular mass of estradiol is 272.38 Da (table 1.1). The structure of estradiol has two
hydroxyl groups. The MS detection of estradiol showed one charged molecular ions [(M-2H)
+2×73]+ at m/z of 416.3 providing evidence of estradiol. Figure 3.9 shows the results for the
molecular ion of estradiol.
25
Figure 3.9: Representative estradiol-2TMS chromatograms and mass spectrum; cholestane was the
internal standard. The molecular ion m/z is 416.3.
7) The molecular mass of testosterone is 288.42 Da (table 1.1). The structure of testosterone has one
ketone group and one hydroxyl group, respectively. The ketone group can be completely converted
to a methoxy group. Testosterone has enantiomers, so after the derivatization, there were two split
peaks with exactly the same fragment information. The MS detection of testosterone showed an
abundance singly charged molecular ions [(M-H) +73+15]+ at m/z of 375.4 providing evidence of
testosterone. This is shown in figure 3.10.
Figure 3.10: Representative testosterone chromatograms and mass spectrum
26
8) The molecular mass of estriol is 288.38 Da (table 1.1). The structure has three hydroxyl groups and
can be silylated completely. The MS detection of estriol showed an abundance singly charged
molecular ions [(M-3H)+3×73]+ at m/z of 504.3 providing evidence of estriol. Figure 3.11 shows
the information about estriol.
Figure 3.11: Representative estriol-3TMS chromatograms and mass spectrum; cholestane was the internal
standard. The molecular ion m/z is 504.3
9) The molecular mass of cortisone is 360.44 Da (table 1.1). The structure of cortisone has three
ketone groups and two hydroxyl groups, respectively. The ketone groups can be completely
converted to methoxy groups. The MS detection of cortisone showed an abundance singly charged
molecular ions [(M-2H) +2×73+3×15]+ at m/z of 549.6 providing evidence of cortisone. The figure
3.12 shows the fragment information about cortisone.
27
Figure 3.12: Representative cortisone-2TMS-3CH3 chromatograms and mass spectrum; cholestane was
the internal standard. The molecular ion m/z is 549.6.
3.2 Optimized derivatization conditions
Silylation conditions such as different silylation reagents (BSA, BSTFA, BSTFA+TMCS, TBDMCI and
HMDS+TMCS+Pyridine (3:1:9)) with different reaction times and reaction temperatures. I also tried to test
different reaction times and reaction temperatures for the methoxylation reaction. To measure the efficiency
of derivatization, we should compare the peak area for each steroid. Table 3.1 shows the results from the
silylation reaction.
Table 3.1. Peak area of every steroid using different silylation reaction condition (methoxylated reaction
condition was the same at 60°C for 45min)
Steroid
BSA BSTFA BSTFA+TMCS HMDS
+TMCS
TBDM
CL
70°C
60min
120°C
30min
70°C
60min
120°C
30min
70°C
60min
120°C
30min
70°C
60min
120°C
30min
AN-TMS 1.115e8 3.837e8 1.745e8 4.420e7 1.868e8 3.072e8 1.112e8 1.868e8
ETIO-
TMS
2.320e8
9.171e8
4.371e8
1.069e8
4.084e8
6.937e8
2.393e8
4.084e8
AN-TMS-
CH3
1.679e8
8.144e8
2.870e8
2.580e8
2.145e8
6.390e8
1.845e8
2.145e8
ETIO-
TMS-CH3
6.147e8
2.611e9
1.050e9
7.680e8
8.279e8
2.051e9
6.571e8
8.279e8
28
DHEA 3.230e8 1.556e9 5.676e8 5.093e8 4.120e8 1.229e9 3.608e8 4.120e8
E1-TMS 1.221e8 5.315e8 2.506e8 7.414e7 2.414e8 4.012e8 1.567e8 2.414e8
E2 4.389e8 1.891e9 8.655e8 5.444e8 6.373e8 1.579e9 5.080e8 6.373e8
E1-TMS-
CH3
1.429e8
9.242e8
3.190e8
2.809e8
2.291e8
7.431e8
2.045e8
2.291e8
T 2.860e8 1.226e9 4.815e8 2.683e8 3.507e8 9.713e8 2.504e8 3.507e8
E3 4.824e8 2.088e9 9.235e8 6.457e8 6.202e8 1.692e9 5.425e8 6.202e8
CHOL 4.384e8 1.517e9 7.778e8 4.763e8 6.181e8 1.475e9 4.736e8 6.181e8
E 2.368e8 9.507e8 5.575e8 3.197e8 4.394e8 1.088e9 5.575e8 4.394e8
*For some unknown errors, I did not collect the data information about HMDS+TMCS at 120°C, 30min
and TBDMCL at 70°C, 60min; *e represents the base 10.
Comparing all the derivatization yield efficiency information, the reactions of BSA and BSTFA+TMCS
(99:1) at 120°C, 30 min seem approximately the same, and better than the other reagents. BSTFA shows
the best result among all the reagents at 70°C, 60min. During 120°C, the efficiency of BSA is much better
than at 70°C; BSTFA shows the opposite result. Finally, BSTFA+TMCS (99:1) and BSA were chosen to
do the experiment for optimization of the methoxylation reaction. The figure 3.13 illustrates that the peak
areas are not much different between BSTFA-TMCS (99:1) and BSA as silylation reagents.
Figure 3.13: the chromatograms (overlaid) for 9 steroids when using BSTFA+TMCS (99:1) and BSA as
silylation reagent. The red color is for BSA and blue color is for BSTFA-TMCS (99:1).
29
After finishing the optimization of the silylation reaction, the silylation condition was set to 120°C, 30min
to continue the experiment for the methoxylation reaction. Table 3.2 shows the result for optimization of
the methoxylation reaction.
Table 3.2 Peak area of every steroid using different methoxylation reaction conditions (silylation reaction
condition was everywhere the same at 120°C for 30min).
Steroid BSA BSTFA + TMCS (99:1)
60°C
30min
60°C
45min
70°C
30min
60°C
30min
60°C
45min
70°C
30min
AN 7.902e8 5.982e8 1.175e9 3.449e8 3.971e8 3.749e8
ETIO 1.932e9 1.430e9 2.897e9 1.073e9 1.160e9 1.058e9
DHEA 1.409e9 1.005e9 2.151e9 7.054e8 8.127e8 7.573e8
E1 9.175e8 7.332e8 1.556e9 4.801e8 6.018e8 5.110e8
E2 9.695e8 6.978e8 1.822e9 4.375e8 5.594e8 5.588e8
E1 4.701e8 2.541e8 6.159e8 1.992e8 2.064e8 1.740e8
T 3.809e7 2.373e7 11.887e7 2.495e7 2.738e7 2.443e7
E3 1.071e9 7.698e8 1.860e9 5.335e8 5.830e8 5.303e8
CHOL 7.986e8 5.225e8 1.329e9 3.616e8 4.232e8 3.338e8
*For some unknown errors, I did not collect the data information about cortisone. *e represents the base 10.
According the results above, BSA shows the best yield efficiency for the methoxylation reaction at 60°C,
30min (figure 3.14); all the conditions for BSTFA + TMCS (99:1) gave the approximately the same yield
efficiency for the methoxylation reaction (figure 3.15). Comparing all the results, using BSA as silylation
reagent at 120°C, 30min and methoxylation condition at 60°C, 30min gives the best derivatization
efficiency. We still, however, wanted to extend the time for the methoxylation reaction to keep all the
analytes stable, and a methoxylation reaction of 60°C, 45min was chosen as the final methoxylation
condition.
30
Figure 3.14: The chromatograms (overlaid) for 9 steroids when using BSA as silylation reagent with
different methoxylated conditions.
Figure 3.15: The chromatograms (overlaid) for 9 steroids when using BSTFA+TMCS (99:1) as silylation
reagent with different methoxylated conditions
31
In this study, that samples reacting with 30µl methoxyamine hydrochloride at 60°C for 45min, then with
100 µL BSA at 120°C for 30 min was the optimized condition.
3.3 Retention times and specificity
The retention times of 9 steroids are shown in Table 3.3, and the gas chromatogram of 9 steroids is shown
in figure 3.16.
Figure 3.16: Gas chromatography of 9 steroids and internal standard. The 9 Steroids were detected via
mass spectrometry after being derivatization. (1) Androsterone-TMS; (2) Androsterone-TMS-CH3; (3)
ETIO-TMS- CH3; (4) DHEA; (5) Estrsdiol; (6) Estrone-TMS-CH3; (7) and (8) Testosterone; (9) Cholestane;
(10) Estriol; (11) Cholestrol; (12) Cortisone.
Table 3.3 Analysis parameters for 9 steroids
Steroids Retention time (min) Fragments (amu)
AN-TMS 6.606 129.0;272.3;347.3;362.3a
AN-TMS-CH3 7.176 129.1;270.3;360.3;377.3a
ETIO-TMS-CH3 7.313 129.1;270.3;360.3;377.3a
DHEA 8.061 129.0; 358.3;360.4a
E2 8.748 129.0;232.3;285.3;416.3a
32
E1-TMS-CH3 8.847 129.1;231.2;340.3;357.4a
T 9.091 and 9.207 129.1;358.3;375.4a
E3 11.576 129.1;147.0;270.2;504.3a
CHOL 12.726 129.0;329.4;368.4;458.5a
E 14.027 129.1;369.3;459.3;549.6a
a represents the qualifier and quantifier ion of each compound.
3.4 Steroid-free experiments
Thin layer chromatography experiments were used for testing the methods of removed the steroids.
Among all the steroids in the human body, cholesterol shows the highest concentration level, so the
standard of cholesterol was chosen as the reference steroid. Figure 3.17 shows the extraction result of
ISOLUTE SI 6 ml SPE column and Figure 3.18 is the result of the charcoal method.
Figure 3.17: SPE extreaction method Figure 3.18: Activated charcoal method
As we can see, cholesterol was not found in the plasma when we used ISOLUTE SI 6 ml SPE column,
and the method with activated charcoal shows that this method cannot remove the steroids.
33
3.5 Method validation
3.5.1 Calibration curve for each steroid
During the experimentation process, various errors occurred at different steps of the assay, so the peak area
ratio between the steroids and internal standard instead of the absolute peak area of steroids, was utilized
to calculate the concentration of steroids in plasma. The peak area ratios were plotted against the
concentration of the steroids (Figure 3.19-3.22). The quality of the linear fit was scrutinized by means
of several statistical analysis methods as presented in the following section.
Figure 3.19: Calibration curve for cholesterol, showing average (n=6) cholesterol to internal standard
peak area ratio versus concentration
y = 0.045x - 0.0792R² = 0.9984
-5.00E-01
0.00E+00
5.00E-01
1.00E+00
1.50E+00
2.00E+00
2.50E+00
3.00E+00
0.00E+00 1.00E+01 2.00E+01 3.00E+01 4.00E+01 5.00E+01 6.00E+01Pe
ak a
rea
of
Ch
ole
ste
rol/
Pe
ak a
rea
of
IS
Cholesterol concentration (µg/mL)
34
Figure 3.20: Calibration curve for estradiol, showing average (n=6) estradiol to internal standard peak
area ratio versus concentration
Figure 3.21: Calibration curve for DHEA, showing average (n=6) DHEA to internal standard peak area
ratio versus concentration
y = 0.0617x - 0.0743R² = 0.9900
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
0.0 10.0 20.0 30.0 40.0 50.0 60.0
Pe
ak a
rea
of
Estr
adio
l/P
eak
are
a o
f IS
Estradiol concentration (g/mL)
y = 0.0322x - 0.1663R² = 0.9833
-0.20
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
1.80
0.0 10.0 20.0 30.0 40.0 50.0 60.0
Pe
ak a
rea
of
DH
EA/P
eak
are
a o
f IS
DHEA Concentration (g/mL)
35
Figure 3.22: Calibration curve for cortisone, showing average (n=6) cortisone to internal standard peak
area ratio versus concentration
3.5.2 Limit of detection (LOD), limit of quantification (LOQ) and precision.
LOD and LOQ were determined as the concentrations producing signal to noise ratio of 3 and 10
respectively. The instrument precision was determined by multiple injections of the samples. All the results
summarized in Table 3.4.
Table 3.4 Relative standard deviation (RSD) values of standard steroid/internal standard peak area ratio at
each concentration and each steroid LOD and LOQ
Concentration
(µg/ml)
RSD (%)
n=6
LOD(µg/ml) LOQ(µg/ml)
Cholesterol
4
10
15
50
25.9
17.0
8.9
8.5
2.6
8.0
Cortisone
50
65
75
100
15.0
31.7
11.0
21.3
62.4
189
4 9.4
y = 0.0032x - 0.1275R² = 0.9312
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
40.0 90.0 140.0 190.0
Pe
ak a
rea
of
Co
rtis
on
e/P
eak
are
a o
f IS
Cortisone concentration (g/mL)
36
DHEA 10
15
50
22.0
26.6
11.2
9.0 27.2
Estradiol
4
10
15
50
10.4
3.6
9.9
4.8
6.6
20.0
3.5.3 Normal sample analysis
The purpose of the steroid quantification method development is eventually to measure concentration of
steroids in normal and patient plasma samples. In this study, we used normal plasma to check what kind of
steroids we can find using this method. After extraction by ISOLUTE SLE + 96-well plates, only
cholesterol can be identified. The chromatogram is shown below (figure 3.23).
Figure 3.23: normal plasma chromatogram
According the peak area ratio and the fitted equation in figure 3.19, concentration of cholesterol is 34.82 ±
1.35µg/ml
3.5.4 Recovery test
The recovery of each steroid (cholesterol, cortisone, DHEA, and cortisone) was estimated as the ratio
between the areas under the peaks of the extracted samples. The spiking level for DHEA, Estradiol, and
Cholesterol was 500ng, 1000ng, 2000ng, 3000ng and 5000ng; recovery level for Cortisone was 5000ng,
7500ng, 10000ng, 12500ng and 15000ng respectively. All the results are illustrated below (table 3.5).
37
Table 3.5 Recovery of four steroids
Recovery (%) Spiking level (ng)
500 1000 2000 3000 5000
Cholesterol 119.49 - 122.35 126.69 125.27
Cortisone 128.88 125.25 127.26 - -
DHEA 99.27 52.70 83.56 - -
Estradiol 149.75 115.20 105.89 - 162.78
A dash represents that I did not collect the data information because some unknown errors.
38
4. Conclusion
The aim of my study was to develop a sensitive, stable and rapid method for the analysis of steroids in
biological tissues by GC-MS, a more reliable technique than the usual immunoassay technique, which
allows also a wide range of steroids to be identified in a single sample. The steroids I tried belonged to the
androgens, estrogens, and corticoids sub-groups. The utilization of different derivatization methods during
the sample preparation part is also important. The developed GC-MS method is robust and reached the level
of sensitivity and reproducibility which is required by clinical testing. Hence, the method can be
incorporated into the daily routine testing of steroids.
5. Future work Future work can possibly explore the derivatization method, looking for effective ways to convert a ketone
group to a methoxy group. In this project my focus was to explore only 5 silylation reagents but in the
future one can also test more reagents. Examples would be looking at MSTFA, TMIS, DTE, (TMSI), HFBA
and TEA or mixing different reagents using different ratio to compatible more steroids which did not test
in this project.
39
6. Acknowledgments
My gratitude to all of you is beyond any words. First of all I would like to Professor Jonas Bergquist for
accepting me to work on this project. You gave me a lot of trusts and helps since the first day we met.
Thank you for trust and giving me the opportunity to switch my master program from another department
2 years ago. Your guidance and encouragement from the start to the end of this project is highly appreciated.
My sincere thanks is to my supervisor Dr. Kumari Ubhayasekara for the continuous guidance valuable
suggestions. You are really like my father as I mentioned before and I’m very lucky to be with you during
these months. You are really cared so much on my work, patience to my questions and explained everything
to me. My sincere thanks is also to Neil De Kock for your valuable helps, good suggestions and enjoyable
discussions during the lab experiments. Also I thank Warunika Aluthgedara, for her kindness, sweet and
valuable discussion. I would also like to thank all the staff at the analytical chemistry department for their
support and making my time fun here. Finally, I would like to give my deepest thanks to my father, for your
many years of enormous support to my study in Sweden. Last but not least, I would like to say thanks to
my boyfriend, Eugene, thank you for your love and support, for your understanding everything of me during
my study.
40
7. Popular scientific summary
Steroids are lipid compounds which can be synthesized from cholesterol. The steroids are mainly divided
into the following catogories: estrogen; androgen; glucocorticoid; progesterone; and mineralocorticoid. The
synthesis of these steroids occurs in the mitochondria and the smooth endoplasmic reticulum of cells in the
adrenal cortex, the gonads and the placenta. The adrenal cortex is mainly responsible for the production of
corticosteroid and androgen hormones which has three zones. Aldosterone and mineralocorticoids are
mainly produced in the outmost zone and zona glomerulosa. The middle zone, zona fasciculate, releases
glucocorticoids such as cortisol and cortisone into the body. Zona reticularis and the innermost zone is
responsible for producing androgens androstenedione (the precursor to testosterone (T)). Estrogens are
produced mainly by the ovaries and placenta with small amounts being produced by the adrenal glands.
These steroids with their metabolites are important in controlling human body functions and regulating the
nervous and immune systems. For example, estrogens could develop and maintain the female secondary
sex characteristics; androgens could develop and maintain the male secondary sex characteristics;
glucocorticoids could be acted as an immunosuppressant; progesterones could maintain the pregnancy and
regulate the cyclical changes of menstruation; and mineralocorticoids could regulate the blood pressure.
In recent years, steroids have became useful biomarkers for the diagnosis of several pathological conditions
and the concentration levels of steroids in the human body could indicate some disorders. Therefore it is
important to develop rapid and accurate analysis methods for steroids.
Currently, the main techniques for the analysis of steroids are immunoassays, liquid chromatography or gas
chromatography coupled to mass spectrometry. The most important requirements for the techniques of
steroid measurement are reliability, specificity and sensitivity. The technique of immunoassays might give
negative results due to cross-reactions, so this technique is not reliable enough. The tandem mass
spectrometry (MS/MS) technique can give reliable, specific and sensitive results, hence mass spectrometry
(MS) coupled with gas chromatography (GC) or high performance liquid chromatography (HPLC) is now
being commonly used in steroid hormone detection.
GC–MS/MS offers a higher resolution compared to LC–MS due to the longer analysis running time and
can analyse volatile compounds, so GC–MS/MS is a powerful tool that can be employed for the analysis
of steroids and is more sensitive than LC–MS. In this study, GC–MS/MS was used for the analysis of
steroids.
41
Normally, biological samples need extraction and an enrichment process for purification before injection
into the instrument. Routine sample preparation usually consists of liquid-liquid extraction (LLE), protein
precipitation and solid phase extraction (SPE). After comparing different techniques, the method of
ISOLUTE SLE + 96-well plates were shown to give high throughput, so this method was used for extraction
of steroids.
Most steroids are required to be derivatized for improving their volatility before injection into GC-MS.
Optimization of derivatizated conditions was investigated for enhancing the derivatization efficiency. In
this study, that samples reacting with 30µl methoxyamine hydrochloride at 60°C for 45min, then with 100
µL BSA at 120°C for 30 min was the optimized condition.
In order to accurately quantify the targeted steroids, the measured response must be correlated with the
concentration of the steroid hormones. Therefore, calibration curves need to be constructed. The calibration
range reflected the steroid concentration levels in the human body and the number of replicates was
sufficient to determine certain parameters and perform various statistical analyses (linearity, precision,
accuracy, sensitivity, stability, limit of detection, etc.). The linearity of the GC-MS method was evaluated
at a concentration range of 2 – 50 µg/ml. The correlation coefficient (R2) of cholesterol and estradiol ≥
0.99; both DHEA and cortisone's parameters ≥ 0.93. The recoveries for all the steroids determined at low,
medium and high concentration levels varied from 52.70 – 162.78 %. The concentration of cholesterol in
normal plasma is 34.82 ± 1.35µg/ml.
The aim of this study was to develop a sensitive, stable and rapid method for the analysis of steroids in
biological tissues by GC-MS, which allows also a wide range of steroids to be identified in a single sample.
The utilization of different derivatization methods during the sample preparation part is also important. The
developed GC-MS method is robust and reached the level of sensitivity and reproducibility which is
required by clinical testing. Hence, the method can be incorporated into the daily routine testing of steroids.
Future work can be done on the derivatization method, to find more effective derivatization methods
compatible with steroids which were not tested in this project.
42
8. References
1. Steroid Chemistry and Steroid Hormone Action. Chapter 1.
2. Synthia H. Mellon and Lisa D. Griffin. Neurosteroids: biochemistry and clinical significance.
Trends in Endocrinology & Metabolism, Volume 13, Issue 1, 1 January 2002, Pages 35-43.
3. M. Terqui a**, J.H.M. Wrathall b, M.A. Driancourt a, P.G. Knight b, Modulation of ovarian
function by steroid and inhibin immunization; Livestock Production Science 42 ( 1995) 181-192
4. Ziad J. Sahab, Suzan M. Semaan and Qing-Xiang Amy Sang, Methodology and Applications of Dis.
Paul J. Taylor,1,2*Donald P. Cooper,3Richard D. Gordon,1 and Michael Stowasser.
Measurement of Aldosterone in Human Plasma by Semiautomated HPLC–Tandem Mass
Spectrometry.ease Biomarker Identification in Human Seru. Biomarker Insights 2007: 2; 21-43.
5. Fouad R. Kandeel, Vivien K. T. Koussa and Ronald S. Swerdloff ; Male Sexual Function and Its
Disorders: Physiology, Pathophysiology, Clinical Investigation, and Treatment; Endocr Rev. 2001
Jun;22(3):342-88
6. Sadava D, Hillis DM, Heller HC, Berenbaum MR (2011). Life: The Science of Biology 9th Edition.
San Francisco: Freeman. pp. 105–114. ISBN 1-4292-4646-4.
7. "Estrone". OSHA. Retrieved 21 February 2013
8. Douma SL, Husband C, O'Donnell ME, Barwin BN, Woodend AK (2005). "Estrogen-related mood
disorders: reproductive life cycle factors". ANS Adv Nurs Sci 28 (4): 364–75.
9. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR (October 2002).
"Treatment of multiple sclerosis with the pregnancy hormone estriol". Ann. Neurol. 52 (4): 421–8.
10. Mo Q, Lu SF, Simon NG (April 2006). "Dehydroepiandrosterone and its metabolites: differential
effects on androgen receptor trafficking and transcriptional activity" . J. Steroid Biochem. Mol.
Biol. 99 (1): 50–8.
11. Bloch M1, Rubinow DR, Berlin K, Kevala KR, Kim HY, Schmidt PJ; Monoamines and
neurosteroids in sexual function during induced hypogonadism in healthy men; Arch Gen
Psychiatry. 2006 Apr;63(4):450-6.
12. Julien F. Blebuyck, M.B., D.Phil; The metabolic response to stress: an overview and update;
Anesthesiology 73: 308-327, 1990.
13. Mooradian AD, Morley JE, Korenman SG (February 1987). "Biological actions of androgens".
Endocr. Rev. 8 (1): 1–28.
14. "Prednisone and other corticosteroids: Balance the risks and benefits". MayoClinic.com. 2010-06-
05.
15. Steven J. Soldin1,2*and Offie P. Soldin1,3,4; Steroid Hormone Analysis by Tandem Mass
Spectrometry; Clin Chem. 2009 Jun;55(6):1061-6. doi: 10.1373/clinchem.2007.100008. Epub
2009 Mar 26.
16. Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, White PC (October 1991).
"The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal
cortex.". Mol. Endocrinol. 5 (10): 1513–1522.
17. Ronald E. Majors, Wilmington,De; sample preparationfundamentals for chromatography
18. C.H. Shackleton, Genetic disorders of steroid metabolism diagnosed by mass spectrometry, in: N.
Blau, M. Duren, K.M. Gibson (Eds.), Laboratory guide to the methods in biochemical genetics, 1st
ed., Springer, Berlin Heidelberg, 2008, pp.549–605.
19. W.J.A. Vanden Heuvel, C.C. Sweeley, E.C. Horning, J. Am; sepration of steroids by gas
chromatography; Chem. Soc. 82 (1960) 3481.
20. Blau, J. Halket, Handbook of Derivatives for Chromatography, second edition, 1993, John Wiley
& Sons Ltd, England.
43
21. Maria Vittoria Cangialosia, Egidio Pucciaa, Antonio Mazzol b, Valentina Mansuet a, Augustine
Arukwec; Screening of ovarian steroidogenic pathway in Ciona intestinalis and its modulation
after tributyltin exposure; Toxicol Appl Pharmacol. 2010 May 15;245(1):124-33. doi:
10.1016/j.taap.2010.03.001. Epub 2010 Mar 7.
22. Sarah Combalbert & Marie-Laure Pype &Nicolas Bernet & Guillermina Hernandez-Raquet;
Enhanced methods for conditioning, storage, and extraction of liquid and solid samples of manure
for determination of steroid hormones by solid-phase extraction and gas chromatography–mass
spectrometry; Anal Bioanal Chem. 2010 Sep;398(2):973-84. doi: 10.1007/s00216-010-3954-7.
Epub 2010 Jul 28.
23. Homma K, Hasegawa T, Masumoto M, Takeshita E, Watanabe K, Chiba H, Kurosawa T, Takahashi
T, Matsuo N; Reference values for urinary steroids in Japanese newborn infants: gas
chromatography/mass spectrometry in selected ion monitoring; Endocr J. 2003 Dec;50(6):783-92.
24. Kai Fang, Xuejun Pan&, Bin Huang, Jingliang Liu, Yu Wang, Jianpei Gao; Simultaneous
Derivatization of Hydroxyl and Ketone Groups for the Analysis of Steroid Hormones by GC–MS;
Chromatographia, November 2010, Volume 72, Issue 9-10, pp 949-956.
25. Philippe Liere, 1,*Antoine Pianos,*Bernard Eychenne,* Annie Cambourg,* Karl Bodin,†William
Griffiths,†,2Michael Schumacher, * Etienne-Emile Baulieu,* and Jan Sjövall†; Analysis of
pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key; J
Lipid Res. 2009 Dec;50(12):2430-44. doi: 10.1194/jlr.M900162-JLR200. Epub 2009 Jun 8.
26. Jin-Aa Oh1and Ho-Sang Shin2; Rapid determination of natural steroidal hormones in saliva for the
clinical diagnoses; Chemistry Central Journal (Impact Factor: 1.31). 03/2012; 6(1):22.
DOI:10.1186/1752-153X-6-22.
27. Martin Hansen. Naja W. Jacobsen. Frederik K. Nielsen. Erla nd Björklund; Determinatio of steroid
hormones in blood by GC–MS/MS; Anal Bioanal Chem. 2011 Jul;400(10):3409-17. doi:
10.1007/s00216-011-5038-8. Epub 2011 May 1.
28. Man Ho Choi and Bong Chul Chung*; GC-MS determination of steroids related to androgen
biosynthesis in human hair with pentafluorophenyldimethylsilyl–trimethylsilyl derivatisation;
Analyst. 1999 Sep;124(9):1297-300.
29. P. A. Voogt,* J. G. D. Lambert, J. C, M. Grannemantt and M, Jansen*; Confirmation of the
presence of oestradiol-17β in sea star Asterias rubens by GC-MS; Comp. Biochem. Physiol. Vol.
101B, No. 1/2, pp. 13-16, 1992.
30. Jun Chen, Qionglin Lianga,∗ , Haiyin Huaa, Yiming Wanga, Guo’an Luoa,∗ ∗ , Mingqiu Hub,
Yanqun Nab; Simultaneous determination of 15 steroids in rat blood via gas chromatography–
mass spectrometry to evaluate the impact of emasculation on adrenal; Talanta. 2009 Dec
15;80(2):826-32. doi: 10.1016/j.talanta.2009.07.066. Epub 2009 Aug 8.
31. Wilfried M.A. Niessen ; Current Practice of Gas Chromatography-Mass Spectrometry; volume 86;
32. Dorgan JF, Fears TR, McMahon RP, Aronson Friedman L, Patterson BH, Greenhut SF.
Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass
spectrometry. Steroids 2002;67:151– 8.
33. Poulson K, Sancho J, Haber E. A simplified radio-immunoassay for plasma aldosterone employing
an antibody of unique specificity. Clin Immunol 1974;2:373– 80.
34. Jonas Abdel-Khalik∗ , Erland Björklund1, Martin Hansen∗ , Simultaneous determination of
endogenous steroid hormones in human and animal plasma and serum by liquid or gas
chromatography coupled to tandem mass spectrometry; J Chromatogr B Analyt Technol Biomed
Life Sci. 2013 Jun 1;928:58-77. doi: 10.1016/j.jchromb.2013.03.013. Epub 2013 Mar 21.
35. Guo T, Chan M, Soldin SJ. Steroid profiles using liquid chromatography tandem mass spectrometry
with atmospheric pressure photoionization source. Arch Pathol Lab Med 2004;128:469 –75.
44
36. Nelson RE, Grebe SK, Okane DJ, Singh RJ. Liquid chromatography-tandem mass spectrometry as-
say for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem 2004;
50:373– 84.
37. Paul J. Taylor,1,2*Donald P. Cooper,3Richard D. Gordon,1 and Michael Stowasser. Measurement
of Aldosterone in Human Plasma by Semiautomated HPLC–Tandem Mass Spectrometry; Clin
Chem. 2009 Jun;55(6):1155-62. doi: 10.1373/clinchem.2008.116004. Epub 2009 Apr 9.
38. B.G. Wolthers, G.P.B. Kraanb,1, Clinical applications of gas chromatography and gas
chromatography–mass spectrometry of steroids; Journal of Chromatography A, 843 (1999) 247–
274.
39. P. Magnisalia, M. Dracopouloub, M. Mataragasc, A. Dacou-Voutetakisb, P. Moutsatsoua,∗ .
Routine method for the simultaneous quantification of 17β-hydroxyprogesterone, testosterone,
dehydroepiandrosterone, androstenedione, cortisol, and pregnenolone in human serum of neonates
using gas chromatography–mass spectrometry; J Chromatogr A. 2008 Oct 10;1206(2):166-77. doi:
10.1016/j.chroma.2008.07.057. Epub 2008 Jul 25.
40. Stefan A. Wudya,∗ , Michaela Hartmanna, Janos Homokib; Determination of 11-deoxycortisol
(Reichstein’s compound S) in human plasma by clinical isotope dilution mass spectrometry using
benchtop gas chromatography–mass selective detection; Steroids Volume 67, Issue 10, September
2002, Pages 851–857.
41. Hans Jorg Leis , Gunter Fauler, Gerald N. Rechberger, Werner Windischhofer. Quantitative trace
analysis of estriol in human plasma by negative ion chemical ionization gas chromatography–mass
spectrometry using a deuterated internal standard; Journal of Chromatography B, 794 (2003)
205–213.
42. K.M. Trippa,1,*, M. Duboisb, P. Delahautb, J.P. Verstegena; Detection and identification of
plasma progesterone metabolites in the female Florida manatee ( Trichechus manatuslatiros tris)
using GC-MS/MS.Theriogenology,2009Aug;72(3):365-71.doi:10.1016/j.theriogenology.
43. Sati C. Chattoraj and Antonio Scommegna with the technical assistance of Leonard Rambow; A
gas chromatographic technique for the simultaneous determination of urinary pregnanediol and
pregnanetriol after ammonium sulfate precipitation; Steroids; Volume 9, Issue 3, March 1967,
Pages 327–346.
44. Liere,P., Y. Akwa , S. Weill-Engerer, B. Eychenne, A. Pianos,P. Robel,J. Sjövall, M. Schumacher ,
and E. E. Baulieu. 2000. Validation of an analytical procedure to measure trace amounts of
neurosteroids in brain tissue by gaschromatography-mass spectrometry; Journal of
Chromatography B, 739 (2000) 301–312.
45. Xu X, Duncan AM, Merz BE, Kurzer MS. Effects of soy isoflavones on estrogen and phytoestrogen
metabolism in premenopausal women; Cancer Epidemiol Biomarkers Prev. 1998; 7:1101–1108.
46. Jeffrey M. McGuire* and Phillip J. Powis. Gas Chromatographic Analysis of Tall Oil
Fractionation Products After Methylation with Ν,Ν-Dimethylformamide Dimethylacetal; Journal
of Chromatographic Science, Vol. 36, February 1998.
47. RAGNAR RYHAGE, Use of a Mass Spectrometer as a Detector and Analyzer for Effluents
Emerging from High Temperature Gas Liquid Chromatography Columns; Anal. Chem., 1964, 36
(4), pp 759–764, DOI: 10.1021/ac60210a019,Publication Date: April 1964.
48. Ivan Miksık , Martina Vylitova , Jirı Pacha , Zdenek Deyla; Separation and identification of
corticosterone metabolites by liquid chromatography–electrospray ionization mass spectrometry;
Journal of Chromatography B, 726 (1999) 59–69.
49. Turpeinen U, Markkanen H, Sane T, Hämäläinen E. Determination of free tetrahydrocortisol and
tetrahydrocortisone ratio in urine by liquid chromatography-tandem mass spectrometry; Scand J
Clin Lab Invest. 2006;66(2):147-59.
45
50. Raffaelli A, Saba A, Vignali E, Marcocci C, Salvadori P. Direct determination of the ratio of
tetrahydrocortisol+allo-tetrahydrocortisol to tetrahydrocortisone in urine by LC-MS-MS; J
Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jan 18;830(2):278-85. Epub 2005 Nov 23.
51. Tatsuya Higashi∗ , Hiroyuki Yokoi, Hitoe Maekubo, Ayako Honda, Kazutake Shimada; Studies on
neurosteroids XXIII. Analysis of tetrahydrocorticosterone isomers in the brain of rats exposed to
immobilization using LC–MS; Steroids, Volume 72, Issue 13, November 2007, Pages 865–874.
52. N. Andrási,A. Helenkár,A. Vasanits-Zsigrai,Gy. Záray,I. Molnár-Perl∗; The role of the acquisition
methods in the analysis of natural and synthetic steroids and cholic acids by gas chromatography–
massspectrometry;J.ChromatogrA.2011Nov11;1218(45):8264-72.doi: 10.1016/j.chroma Epub
2011 Sep 14.
53. Jin Wei, Huang Bin, Wang Bin, Wang Dao-Wei, Zhao Shi-Min, Pan Xue-Jun*, Simultaneous
Determination of Androgens and Progestogen in Surface Water and Sediment by Gas
Chromatography-Mass Spectrometr; Chinese Journal of Analytical Chemistry 2013-2-14, 205-209
54. Nils Krone,[low asterisk] Beverly A. Hughes, Gareth G. Lavery, Paul M. Stewart, Wiebke Arlt, and
Cedric H.L. Shackleton; Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent
discovery tool in clinical steroid investigations even in the era of fast liquid chromatography
tandem mass spectrometry (LC/MS/MS); J Steroid Biochem Mol Biol. Aug 2010; 121(3-5): 496–
504.
55. Eunjung Han,Okkyoung Yim,Sun-young Beak; Determination of Adrenosterone and its Metabolites
in Human Urine by LC/APCI/MS and GC/MS; Bull. Korean Chem. Soc. 2009 , Vol. 30, No. 7,1489
56. S. AbuRuz, J. Millership, L. Heaney, J. McElnay, J. Chromatogr. B 798 (2003) 193.